<DOC>
	<DOCNO>NCT02990195</DOCNO>
	<brief_summary>Multicentre prospective human experimental study determine effect chyme reinfusion patient double enterostomy plasma level Fibroblast Growth Factor ( FGF19 )</brief_summary>
	<brief_title>Restoring Beneficial Effects Enterohepatic Bile Salt Signalling Chyme Reinfusion Patients With Double Enterostomy</brief_title>
	<detailed_description>Patients support chyme reinfusion follow 3 day pre chyme reinfusion 7 week chyme reinfusion . Three day prior chyme reinfusion , baseline characteristic determine , ileal biopsy , blood , chyme urine collect . Furthermore , blood , chyme , faeces urine collect first day chime reinfusion . These material collect week 1 , 3 , 5 7 week initiation chyme reinfusion . A second ileal biopsy perform week 3 .</detailed_description>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Age equal 18 year old Temporary double enterostomy treat chyme reinfusion routine primary care Downstream bowel least 25 cm healthy small bowel , accessible stoma , suitable chyme reinfusion ileal biopsy In case enterocutaneous fistula , diagnosis fistula origin localization confirm additional medical imaging ( computerized tomography/fistulography ) Written informed consent . Patients mental disability Pregnancy lactation Hepatocellular carcinoma Blood coagulation disorder Shock cause Patients subject major legal protection ( safeguard justice , guardianship , trusteeship ) , person deprive liberty</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>